Skip to content

A randomized controlled study for extracorporeal shock wave combined with peri-hip muscle training in the treatment of patellar tendinosis

A randomized controlled study for extracorporeal shock wave combined with peri-hip muscle training in the treatment of patellar tendinosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022882
Enrollment
Unknown
Registered
2019-04-29
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patellar tendon disease

Interventions

Group 2:Extracorporeal shock wave therapy +medication
Group 3:Peri-hip muscle strength training +medicaton
Group 4:Extracorporeal shock wave therapy +Peri-hip muscle strength training +medication

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-50 years, male or female; 2. Satisfy the tenderness of patellar apical and patellar tendon at the same time. On MRI, patients with high signal intensity of patellar tendon in the lower part of patellar apex; 3. Receive Exercise therapy. 4. Understanding and signing of informed consent

Exclusion criteria

Exclusion criteria: 1. A patient with dislocation of the patella, malacia of the patella, fracture of the patella, bipartite patella, tear of the patellar ligament, or multiple ligament injury; 2. There were early changes in osteoarthritis; 3. Other causes of pain, such as diabetic neuropathy, 4. The patients received external analgesic drugs or oral analgesic drugs within 4 weeks before admission, physical therapy or blocking therapy within 2 weeks, etc.; 5. Systemic diseases such as lupus erythematosus, ankylosing spondylitis, gout, etc.; 6. Received knee surgery; 7. Cases involving compensation for (work-related injuries); 8. Complicated with serious medical diseases, heart, brain, kidney and other diseases; 9. Participate in other clinical researchers within half a year; 10. Associated with mental and cognitive diseases; 11. Pregnant women; 12. has shock wave therapy contraindication.

Design outcomes

Primary

MeasureTime frame
VAS pain score;Knee Injury and Osteoarthritis Outcome Score (KOOS);Tegner Activity Score (TAS);MRI;Isokinetic muscle strength test;

Countries

China

Contacts

Public ContactYunxia Li

Huashan Hospital, Fudan University

Liyunxia912@aliyun.com+86 13701603574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026